Warburg Research set a €36.00 ($41.86) price target on Evonik Industries (FRA:EVK) in a research report released on Thursday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.
Other equities research analysts have also recently issued research reports about the company. UBS Group set a €23.00 ($26.74) price target on Evonik Industries and gave the company a sell rating in a research note on Thursday, July 11th. Morgan Stanley set a €34.00 ($39.53) price target on Evonik Industries and gave the company a buy rating in a research note on Monday, July 15th. Credit Suisse Group set a €28.00 ($32.56) price target on Evonik Industries and gave the company a neutral rating in a research note on Friday, April 12th. Nord/LB set a €24.00 ($27.91) price target on Evonik Industries and gave the company a neutral rating in a research note on Thursday. Finally, Barclays set a €27.00 ($31.40) price target on Evonik Industries and gave the company a neutral rating in a research note on Thursday, May 2nd. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and ten have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and an average target price of €30.83 ($35.85).
Shares of Evonik Industries stock traded down €1.24 ($1.44) on Thursday, reaching €23.41 ($27.22). 1,495,950 shares of the company were exchanged. Evonik Industries has a one year low of €26.78 ($31.14) and a one year high of €32.97 ($38.34). The firm’s 50-day moving average is €25.50.
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.